Table 3.

Summary of the triple-negative status of the hereditary breast cancer cohort.

Group	Number of Patients	BARD1-Mutated
TNBC patients	680	10 (0.88%) OR = 5.40 (1.77–18.15) p = 0.001 **
Non-TNBC patients	2179	6 (0.28%)
Total	2859	16

TNBC: triple-negative breast cancer; OR: odds ratio. ** α < 0.01.